Social Media Perceptions Among Young Adults With Cancer - Online Experiment 1 (SIYA MOS1)
Young adults with cancer experience more loneliness than their non-cancer peers or older cancer survivors. Positive psychology interventions may increase social connectedness; however, evidence-based interventions should be tailored to young adults with cancer and designed for social media. This study conducted an online experiment with young adults with cancer (ages 22-39) to optimize intervention messages.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
To examine how message types and personal stories influence reactions, the study used a mixed between-within online experiment. The researchers hypothesized that four message types (connected peer advocates, lonely peer advocates, cancer peers, and clinicians) would lead to greater perceived message effectiveness in encouraging positive in-person social interactions and stronger intended message reactions compared with control messages (H1). They also hypothesized that including a personal story (cancer-related or general) would improve perceived message effectiveness and intended message reactions (H2). Unintended message reactions were also explored.
Tipo de estudio
Tipo de estudio
Inscripción (Actual)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
North Carolina
-
Chapel Hill, North Carolina, Estados Unidos, 27599
- University of North Carolina at Chapel Hill
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Participants must be 22-39 years old at the time of the study
- Participants must have received a cancer diagnosis at any point between ages 15-39
- Participants must self-report low-to-moderate psychosocial quality of life (QOL), defined as an average rating of 4 or lower on the National Institutes of Health's (NIH's) validated 2-item Patient Reported Outcomes Measurement Information System (PROMIS) global mental health scale (two 5-point items)
- Participants must use social media
Exclusion Criteria:
- None
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: Connected advocate advice
Participants viewed five social media-based messages consisting of photographs of peers who are cancer advocates who have successfully created social connections and captions with advice for having more in person connections. |
Participants were randomized to 1 of 5 message conditions. |
|
Experimental: Lonely advocate advice
Participants viewed five social media-based messages consisting of photographs of peers who are cancer advocates who are experiencing loneliness but still try to have social connections and captions with advice for having more in person connections. |
Participants were randomized to 1 of 5 message conditions. |
|
Experimental: Peer-to-peer sharing
Participants viewed five social media-based messages consisting of peer-to-peer sharing about connecting with others and captions with advice for having more in person connections. |
Participants were randomized to 1 of 5 message conditions |
|
Experimental: Clinician advice
Participants viewed five social media-based messages consisting of photographs of clinicians and captions with advice for having more in person connections. |
Participants were randomized to 1 of 5 message conditions. |
|
Experimental: Control messages
Participants were randomized to 1 of 5 message conditions. |
Participants were randomized to 1 of 5 message conditions. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Perceived Message Effectiveness (Single-Item Self-Report, 5-Point Scale)
Periodo de tiempo: Baseline, Up to 1 hour
|
After viewing each of 5 social media posts, participants answered one item: "How much does this post make you want to connect in person with people you barely know more often?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived message effectiveness. Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Positive Affect (Single-Item Self-Report, 5-Point Scale)
Periodo de tiempo: Baseline, Up to 1 hour
|
After viewing each of 5 social media posts, participants answered one item: "How good does viewing this post make you feel?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater positive affect. Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
|
Perceived Social Presence (Single Item Adapted From Lazard et al., 2020; 5-Point Scale)
Periodo de tiempo: Baseline, Up to 1 hour
|
After viewing each of 5 social media posts, participants answered one item: "When viewing this post, how much do you feel as if someone is talking to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived social presence. Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
|
Message Relevance (Single Item Adapted From Jensen et al., 2024; 5-Point Scale)
Periodo de tiempo: Baseline, Up to 1 hour
|
After viewing each of 5 social media posts, participants answered one item: "How relevant is this post to you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived relevance. Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
|
Attention (Single Item Adapted From Sutfin et al., 2019; 5-Point Scale)
Periodo de tiempo: Baseline, Up to 1 hour
|
After viewing each of 5 social media posts, participants answered one item: "How much does this post grab your attention?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater attention. Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
|
Perceived Authenticity (Single-Item Self-Report, 5-Point Scale)
Periodo de tiempo: Baseline, Up to 1 hour
|
After viewing each of 5 social media posts, participants answered one item: "How much do you think this post shares a real perspective?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater perceived authenticity. Ratings were compared across experimental conditions and message type. |
Baseline, Up to 1 hour
|
Otras medidas de resultado
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Negative Affect, Unintended Reaction (Single-Item Self-Report, 5-Point Scale)
Periodo de tiempo: Baseline, Up to 1 hour
|
After viewing each of 5 social media posts, participants answered one item: "How bad does viewing this post make you feel?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater negative affect (a less favorable reaction). Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
|
Reactance, Unintended Reaction (Single Item Adapted From Hall et al., 2017; 5-Point Scale)
Periodo de tiempo: Baseline, Up to 1 hour
|
After viewing each of 5 social media posts, participants answered one item: "How much does this post annoy you?" Response options ranged from 1 (not at all) to 5 (very much); higher scores indicate greater reactance (a less favorable reaction). Ratings were compared across experimental conditions and message types. |
Baseline, Up to 1 hour
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Investigadores
Investigadores
- Investigador principal: Allison J Lazard, PhD, UNC Lineberger Comprehensive Cancer Center
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Actual)
Finalización primaria
Finalización del estudio (Actual)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- SIYA MOS1 Online Experiment 1
- R01CA276176 (Subvención/contrato del NIH de EE. UU.)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .